Cohorte Lausannoise
The objectives of the population-based CoLaus study are to:
1. Determine the prevalence and severity of major cardiovascular risk factors (CVRFs) and cardiovascular disease (CVD) in the population of Lausanne, Switzerland;
2. Find new biological and genetic determinants of CVD, as well as clusters of CVRFs like the metabolic syndrome.
Overview
- Acronym
- CoLaus
- Website
- CoLaus
- Investigators
-
- Contacts
-
General Design
- Study design
- Cohort
- Start - End Year
- 2003 -
- General Information on Follow Up (profile, frequency)
-
Participants were first seen in 2003 to 2006.They were followed-up first from 2009 to 2012, second from 2014 to 2017 and third from 2018 to 2021.
- Recruitment Target
-
- Individuals
- Number of Participants
- 6,734
- Number of Participants with Biological Samples
- 6,734
Access
Availability of data and biosamples
| Possible Access to Data | |
| Possible Access to Biosamples | |
| Other |
|
Marker Paper
Firmann M, Mayor V, Vidal PM, Bochud M et al. The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovascular Disorder, 2008; Mar 17;8:6.
PUBMED 18366642Timeline
Population
CoLaus population
The population is composed of predominantly Caucasian, Lausanne inhabitants, aged 35–75 years.
Selection Criteria
- Minimum age
-
35
- Maximum age
-
75
- Countries
-
- Switzerland
- Territory
- Lausanne
- Ethnic Origin
-
- Partially Caucasian
- Supplementary Information about selection criteria
-
As a selection criteria, participants were originally Caucasian but changed later on to partial caucasian.
Sources of Recruitment
- General Population
-
- Selected sample
- Supplementary Information
-
A random sampling procedure based on a complete list of the Lausanne inhabitants aged 35–75 years, provided by the population register of the city, was used. Subjects who volunteered to participate were contacted by phone within 14 days. Subjects who didn't answer were sent a second invitation letter. If no answer was obtained, they were contacted by phone.
Sample Size
- Number of Participants
- 6,734
- Number of Participants with Biological Samples
- 6,734
- Supplementary Information about selection criteria
-
Baseline: 6734 participants
Follow-up 1: 5064 participants
Follow-up 2: 4881 participants
Follow-up 3: 3972 (ongoing) participants
Data Collection Events
| # | Name | Data sources | Data sources - Biosamples | Start | End |
|---|---|---|---|---|---|
| 0 | CoLaus - Baseline |
|
|
2003 (January) | 2006 (April) |
| 1 | CoLaus - Follow-up 1 |
|
|
2009 (January) | 2012 (April) |
| 2 | CoLaus - Follow-up 2 |
|
|
2014 (January) | 2017 (April) |
| 3 | CoLaus - Follow-up 3 |
|
|
2018 (January) | 2021 (April) |
Participating Studies
| Acronym | Name | Study design | Countries |
|---|
Harmonization Initiatives Included
| Acronym | Name |
|---|
Datasets
| Name | Data Collection Events | Variables |
|---|
Areas of Information Collected
- Socio-demographic and economic characteristics
- Death
- Lifestyle and behaviours
- Physical measures and assessments
- Birth, pregnancy and reproductive health history
- Laboratory measures
- Perception of health, quality of life, development and functional limitations
- Cognition, personality and psychological measures and assessments
- Diseases
- Life events, life plans, beliefs and values
- Symptoms and signs
- Preschool, school and work life
- Medication and supplements
- Social environment and relationships
- Non-pharmacological interventions
- Physical environment
- Health and community care services utilization
- Administrative information
Variables Content Summary
Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected
Networks
| Acronym | Name | Harmonization Initiatives | Individual Studies |
|---|
Last Update: 2021-05-03T10:40:44.746